Researchers from Europe believe they have busted open the link between the AstraZeneca COVID-19 vaccine and blood clots.
Researchers from Europe believe they have found the cause of rare blood clots showing up in patients that have received the AstraZeneca COVID-19 vaccine.
A group of German researchers led by professor Andreas Greinacher at the University of Greifswald, who analyzed 13 cases of cerebral blood clots reported in Germany, found that all of the cases occurred between four and 16 days after the AstraZeneca vaccine was administered.
In four cases, Greinacher said that researchers were able to isolate and identify specific antibodies that were found to provoke an immune reaction that led to cerebral blood clots.
Professor Pal Andre Holme spoke to VG, a Norwegian newspaper, and said, “Our theory that this is a strong immune response that most likely comes after the vaccine”, which is very much the same theory that has come out of Greinacher and his team in Germany. Holme also said, “There is no other thing than the vaccine that can explain this immune response.”
Additionally, Holme stated there’s “no other history in these patients that can give such a strong immune response. I’m pretty sure it’s these antibodies that’s the cause, and I see no other reason than that it’s the vaccine that triggers it.”
If the researchers are correct, it means that medical professionals will be able to treat these rare cases of blood clots.